The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society, Urology, vol.61, issue.1, pp.37-49, 2003. ,
A RATional choice for translational research?, Dis. Model Mech, vol.9, issue.10, pp.1069-1072, 2016. ,
Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation, Am. J. Physiol. Renal Physiol, vol.305, issue.1, pp.111-122, 2013. ,
Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder, Eur. J. Pharmacol, vol.707, issue.1-3, pp.32-40, 2013. ,
Animal Modelling of Interstitial Cystitis/ Bladder Pain Syndrome, Int. Neurourol. J, vol.22, issue.1, 2018. ,
Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences, J. Urol, vol.170, issue.3, pp.1008-1012, 2003. ,
Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain, J. Urol, vol.164, issue.1, pp.203-208, 2000. ,
Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice, Neurourol. Urodyn, vol.30, issue.8, pp.1659-1665, 2011. ,
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis, Neurourol. Urodyn, vol.36, issue.4, pp.1178-1186, 2017. ,
Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats, Pharm. Res, vol.15, issue.11, pp.1792-1795, 1998. ,
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium, J. Physiol, vol.562, pp.859-871, 2005. ,
Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey, Can. Urol. Assoc. J, vol.8, issue.9, pp.721-727, 2014. ,
Cyclophosphamide cystitis-identification of acrolein as the causative agent, Biochem. Pharmacol, vol.28, issue.13, pp.90222-90225, 1979. ,
Role of transient receptor potential vanilloid 4 in rat joint inflammation, Arthritis Rheum, vol.64, issue.6, pp.1848-1858, 2012. ,
How do patients with interstitial cystitis present?, J. Urol, vol.166, issue.6, pp.65517-65523, 2001. ,
EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen, EAU Annual Congress (Copenhagen). EAU Guidelines Office, 2018. ,
EAU guidelines on chronic pelvic pain, Eur. Urol, vol.57, issue.1, pp.35-48, 2010. ,
Visceral and cutaneous sensory testing in patients with painful bladder syndrome, Neurourol. Urodyn, vol.24, issue.7, pp.627-632, 2005. ,
Pain thresholds in women with chronic pelvic pain, Curr. Opin. Obstet. Gynecol, vol.26, issue.4, pp.253-259, 2014. ,
The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors, Physiol. Rep, vol.2, issue.3, p.260, 2014. ,
Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy, J. Urol, vol.136, issue.2, pp.44929-44938, 1986. ,
Current best practice management of interstitial cystitis/bladder pain syndrome, Ther. Adv. Urol, vol.10, issue.7, pp.197-211, 2018. ,
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment, J. Urol, vol.193, issue.5, pp.1545-1553, 2015. ,
Analysis of long-term Elmiron therapy for interstitial cystitis, Urology, vol.49, pp.93-99, 1997. ,
Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis, J. Urol, vol.144, issue.4, pp.39611-39619, 1990. ,
Suicidal ideation among patients with bladder pain syndrome/interstitial cystitis, Urology, vol.80, issue.2, pp.280-285, 2012. ,
COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat, Am. J. Physiol. Regul. Integr. Comp. Physiol, vol.284, issue.2, 2003. ,
, Rats! Dis. Model Mech, vol.2, issue.5-6, pp.206-210, 2009.
Clinical features and spectrum of light microscopic changes in interstitial cystitis, J. Urol, vol.143, issue.6, pp.1118-1124, 1990. ,
Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats, Folia Med. Cracov, vol.48, issue.1-4, pp.74821-74824, 2007. ,
Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice, Toxicol. Appl. Pharmacol, vol.114, issue.1, pp.1-8, 1992. ,
Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome, J. Urol, vol.184, issue.3, pp.958-963, 2010. ,
Discrimination between the ulcerous and the nonulcerous forms of interstitial cystitis by noninvasive findings, J. Urol, vol.155, issue.1, pp.87-90, 1996. ,
Effect of low-dose triple therapy using gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug for overactive bladder symptoms in patients with bladder pain syndrome, Int. Neurourol. J, vol.17, issue.2, pp.78-82, 2013. ,
Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization, J. Urol, vol.191, issue.5, pp.1294-1299, 2014. ,
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence, Ther. Adv. Urol, vol.8, issue.2, pp.91-99, 2016. ,
Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug, Int. Neurourol. J, vol.14, issue.4, pp.256-260, 2010. ,
Mutagenicity of acrolein and acroleininduced DNA adducts, Toxicol. Mech. Methods, vol.20, issue.1, pp.36-44, 2010. ,
Inflammation characteristics in bladder pain syndrome ESSIC type 3C/ classic interstitial cystitis, Int. J. Urol, vol.21, issue.1, pp.75-78, 2014. ,
How are we going to make progress treating bladder pain syndrome? ICI-RS 2013, Neurourol. Urodyn, vol.33, issue.5, pp.625-629, 2014. ,
Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC), Low. Urin. Tract. Symptoms, vol.10, pp.3-11, 2018. ,
Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis, Chem. Biol. Interact, vol.203, issue.2, pp.440-447, 2013. ,
Interstitial cystitis: early diagnosis, pathology, and treatment, Urology, vol.12, issue.4, pp.90286-90294, 1978. ,
Interstitial cystitis: an unsolved enigma, Clin. J. Am. Soc. Nephrol, vol.4, issue.11, pp.1844-1857, 2009. ,
Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis, J. Urol, vol.173, issue.6, pp.1983-1987, 2005. ,
An endogenous pain control system is altered in subjects with interstitial cystitis, J. Urol, vol.191, issue.2, pp.364-370, 2014. ,
Interstitial cystitis: Clinical manifestations and diagnostic criteria in over 200 cases, Neurourol. Urodynamics, vol.9, issue.3, pp.241-250, 1990. ,
The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis, Urology, vol.69, issue.4, pp.9-16, 2007. ,
Cyclophosphamide-induced hemorrhagic cystitis in rats that underwent colocystoplasty: experimental study, J. Urol, vol.165, issue.2, pp.660-666, 2001. ,
Gender specific pelvic pain severity in neurogenic cystitis, J. Urol, vol.187, issue.2, pp.715-724, 2012. ,
Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain, Tech. Urol, vol.7, issue.1, pp.47-49, 2001. ,
Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders, Urology, vol.11, issue.3, pp.215-220, 1978. ,
Species differences in the genotoxicity of cyclophosphamide and styrene in three in vivo assays, Mutat. Res, vol.271, issue.1, pp.49-58, 1992. ,
Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis, Urology, vol.73, issue.2, pp.421-426, 2009. ,
Interstitial cystitis and systemic autoimmune diseases, Nat. Clin. Pract. Urol, vol.4, issue.9, pp.484-491, 2007. ,
Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association, PloS One, vol.3, issue.12, p.3898, 2008. ,
Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation, Exp. Biol. Med. (Maywood), issue.5, pp.620-626, 2008. ,
Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation, J. Comp. Neurol, vol.370, issue.2, pp.191-202, 1996. ,
The urogenital and rectal pain syndromes, Pain, vol.73, issue.3, pp.76-82, 1997. ,
Central sensitization: implications for the diagnosis and treatment of pain, Pain, vol.152, issue.3, 2011. ,